Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.37 AED | 0.00% | +0.85% | -4.05% |
Apr. 30 | Borouge Posts Higher Q1 Attributable Profit; Revenue Down | MT |
Apr. 30 | Borouge plc Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Summary
- From a short-term investment perspective, the company presents a deteriorated fundamental configuration.
Strengths
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
- This company will be of major interest to investors in search of a high dividend stock.
Weaknesses
- The group shows a rather high level of debt in proportion to its EBITDA.
- The company's enterprise value to sales, at 12.86 times its current sales, is high.
- The company appears highly valued given the size of its balance sheet.
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- For the last four months, EPS estimates made by Standard & Poor's analysts have been revised downwards.
Ratings chart - Surperformance
Sector: Specialty Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-4.45% | 19.39B | - | ||
-10.37% | 5.49B | A- | ||
+5.16% | 4.19B | B | ||
+16.45% | 1.59B | B | ||
+3.59% | 1.31B | B- | ||
+19.82% | 959M | - | ||
-11.55% | 688M | - | - | |
-36.36% | 566M | - | ||
-13.97% | 290M | - | - | |
-12.92% | 252M | - | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- BOROUGE Stock
- Ratings Borouge plc